From Illumina to GE, MAQC Participants Use Study's Results as Marketing Touchstone | GenomeWeb
BOSTON Illumina wants you to “buy another vowel” and “switch to i.” GE Healthcare’s CodeLink unit wants you to know that it is number one when it comes to detection sensitivity. And Affymetrix wants you to know that it is still the “gold standard” when it comes to gene expression.
These are some of the ways in which array firms have used the recent publication of the results of the Microarray Quality Control project to increase interest in their products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.